For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Lexaria Bioscience Corp’s stock clocked out at $1.35, down -20.12% from its previous closing price of $1.69. In other words, the price has decreased by -$20.12 from its previous closing price. On the day, 0.6 million shares were traded.
Ratios:
To gain a deeper understanding of LEXX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.24 and its Current Ratio is at 4.24. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 03 ’24 when CHRISTOPHER RICHARD bought 27,172 shares for $2.47 per share. The transaction valued at 67,175 led to the insider holds 50,000 shares of the business.
CHRISTOPHER RICHARD bought 22,828 shares of LEXX for $51,217 on Dec 02 ’24. The Chief Executive Officer now owns 22,828 shares after completing the transaction at $2.24 per share. On Aug 12 ’24, another insider, TURKEL CATHERINE C., who serves as the Director of the company, bought 1,600 shares for $3.13 each. As a result, the insider paid 5,008 and bolstered with 3,100 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 44.72 while its Price-to-Book (P/B) ratio in mrq is 3.30.
Stock Price History:
Over the past 52 weeks, LEXX has reached a high of $4.44, while it has fallen to a 52-week low of $1.15. The 50-Day Moving Average of the stock is -9.53%, while the 200-Day Moving Average is calculated to be -42.92%.
Shares Statistics:
A total of 17.45M shares are outstanding, with a floating share count of 16.28M. Insiders hold about 7.31% of the company’s shares, while institutions hold 8.31% stake in the company.
